851 filings
Page 8 of 43
4
TVTX
Travere Therapeutics Inc
12 May 22
Travere Therapeutics / STEVE ASELAGE ownership change
8:35pm
4
Poole Sandra
12 May 22
Travere Therapeutics / Sandra Poole ownership change
8:33pm
4
Orwin John A
12 May 22
Travere Therapeutics / John A Orwin ownership change
8:30pm
4
Meckler Jeffrey A
12 May 22
Travere Therapeutics / Jeffrey A Meckler ownership change
8:26pm
4
TVTX
Travere Therapeutics Inc
12 May 22
Travere Therapeutics / GARY A LYONS ownership change
8:24pm
4
TVTX
Travere Therapeutics Inc
12 May 22
Travere Therapeutics / TIMOTHY COUGHLIN ownership change
8:22pm
4
Bruhn Suzanne Louise
12 May 22
Travere Therapeutics / Suzanne Louise Bruhn ownership change
8:20pm
4
Baynes Roy D.
12 May 22
Travere Therapeutics / Roy D. Baynes ownership change
8:18pm
8-K
TVTX
Travere Therapeutics Inc
12 May 22
Departure of Directors or Certain Officers
5:26pm
10-Q
2022 Q1
TVTX
Travere Therapeutics Inc
Quarterly report
5 May 22
5:00pm
8-K
TVTX
Travere Therapeutics Inc
5 May 22
Travere Therapeutics Reports First Quarter 2022 Financial Results
12:00am
8-K
TVTX
Travere Therapeutics Inc
20 Apr 22
Departure of Directors or Certain Officers
4:41pm
DEF 14A
TVTX
Travere Therapeutics Inc
Definitive proxy
4 Apr 22
5:29pm
8-K
TVTX
Travere Therapeutics Inc
21 Mar 22
Other Events
4:09pm
8-K
TVTX
Travere Therapeutics Inc
11 Mar 22
Travere Announces Proposed Convertible Senior Notes Offering
4:06pm
424B5
TVTX
Travere Therapeutics Inc
9 Mar 22
Prospectus supplement for primary offering
4:20pm
FWP
TVTX
Travere Therapeutics Inc
9 Mar 22
Free writing prospectus
4:08pm
FWP
TVTX
Travere Therapeutics Inc
8 Mar 22
Free writing prospectus
9:56pm
424B5
TVTX
Travere Therapeutics Inc
8 Mar 22
Prospectus supplement for primary offering
7:41am
10-K
2021 FY
TVTX
Travere Therapeutics Inc
Annual report
24 Feb 22
5:23pm